课题基金 / 基金详情

CORE--CELL BIOLOGY AND IMMUNOTOXICOLOGY

CORE--CELL BIOLOGY AND IMMUNOTOXICOLOGY
核心--细胞生物学和免疫毒理学
批准号:
6575643
负责人:
MARK E LEID
金额:
$7.89万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-04-01 至 2003-03-31

项目摘要

项目成果

MARK E LEID的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Description: The Cell Biology and Immunotoxicology Research Core serves as a biologically oriented complement to the Chemical/Analytical Cores of the OSUEHS Center to provide a focus of relevance to human health for application of the chemical and physical approaches and expertise available within the other Cores. Thus the Core provides a medium for the initiation of research projects in directions that otherwise may not have been pursued. Core leadership has changed from Dr. Barnes (who left OSU in 1997) to Dr. Leid. Drs. Bayne, Kerkvliet and Reed continue to be in this Core and are joined by recent Center investigators: Drs. Greenwood, Hagen, Ishmael and Vella. Dr. Hedstrom (Associate member of Center) also remains associated with this research core. In addition, there are 2 postdoctoral, 17 graduate students and 12 research assistants. The objectives of this Core are to provide an intellectual resource for pursuits into cellular signaling and hormonal/cytokine control of growth, differentiation, early development and mechanisms of cell death. Specific projects by investigators of this Core include: analysis of T cells with regard to TCDD or Ah receptor and peroxisome proliferators; immunomodulation by xenobiotics; oxidative stress, including mitochondrial dysfunction, glutathione and protein thiols, with regard to cell death and immunotoxicity; age-related effects on mitochondrial functions. This Core serves as a biologically oriented complement to the Chemical/Analytical Cores to provide "a focus of relevance to human health for application of chemical and physical approaches". This Core has assisted with 97 publications since 1995 with about 16 being collaborative studies. Eight past collaborative projects are listed [Dr. Kerkvliet (4); Dr. Barnes (2); Dr. Reed (1);and Dr. Leid (1)]. Future plans include additional joint projects with the more recent Center investigators, e.g., projects between Drs. Ishmael and Leid (cloning PAR. alpha transcriptional coactivators); Drs. Kerkvliet and Ishmael (new cell cultures models to assess cell cycle after exposure to nongenotoxic carcinogens); Drs. Reed and Hagen role of glutathione, iron and vitamin E on myocytes; Drs. Kerkvliet, Reed and Hagen (role of glutathione and vitamin E in apoptosis of lymphocytes); Drs. Kerkvliet, Vella, Leid and Hedstrom (TCDD effects on dendritic cells). Drs. Kerkvliet and Vella will provide the immunological expertise for this Core with Drs. Leid and Reed providing biochemical and molecular expertise. This Core provides biological bridging with the other Cores and Center investigators with support for experimental design fostered through workshops and monthly laboratory meetings.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of BCL11B in development of the craniofacial skeleton
  • 批准号:
    9351840
  • 项目类别:
  • 资助金额:
    $44.1万
  • 财政年份:
    2017
  • 负责人:
    MARK E LEID
  • 依托单位:
The Ctip2/Bcl11b transcriptional network in tooth development
  • 批准号:
    8101554
  • 项目类别:
  • 资助金额:
    $29.15万
  • 财政年份:
    2011
  • 负责人:
    MARK E LEID
  • 依托单位:
Role of GRASP in Retinoic Acid Signaling Pathways
  • 批准号:
    7559172
  • 项目类别:
  • 资助金额:
    $18.92万
  • 财政年份:
    2007
  • 负责人:
    MARK E LEID
  • 依托单位:
Creation of CTIP1 and CTIP2 Null Mice
  • 批准号:
    6340542
  • 项目类别:
  • 资助金额:
    $1.88万
  • 财政年份:
    2001
  • 负责人:
    MARK E LEID
  • 依托单位:
海外基金